InvestorsHub Logo
Followers 14
Posts 1420
Boards Moderated 0
Alias Born 06/10/2012

Re: None

Sunday, 04/14/2019 9:42:05 AM

Sunday, April 14, 2019 9:42:05 AM

Post# of 852
8 K out for Zander....On April 10, 2019 Zander Therapeutics, Inc. (“Zander”) entered into an agreement (“Agreement”) with Mr. John Lazor whereby Mr. Lazor shall serve as a member of Zander’s Business Advisory Board.

The term of the Agreement shall commence on April 15, 2019 and expire on April 15, 2022. The term of the Agreement may be extended by mutual agreement.

Pursuant to the Agreement:

(a) Mr. Lazor shall, for so long as he remains a member of the Business Advisory Board, meet with Zander upon written request, at dates and times mutually agreeable to Candidate and Zander, to discuss any matter involving Zander or its Subsidiaries
(b) Identify and introduce to Zander persons to serve as members of Zander's Business Advisory Board ("Advisory Candidates").
(C) Identify and introduce to Zander potential purchasers of Zander’s securities.

Pursuant to the Agreement:

(i) Mr. Lazor received 50,000 of the common shares of Zander.